Karen Facey

Metrics Downloaded 0 times History Received 21 March 2019 Accepted 3 April 2019 Published online 22 May 2019 Information © 2019 Future Medicine Ltd KeywordsAcknowledgments This work is inspired by the author’s colleagues in the HTA international Interest Group and the HTA bodies and patient organizations she has worked with to develop processes to elicit the unique knowledge of patients that she knows can improve HTA decision making.

Request Username Can't sign in? Forgot your username? Enter your email address below and we will send you your username Username or Email: If the address matches an existing account you will receive an email with instructions to retrieve your username

To ensure consistency and alignment between Member States, avoid duplication of evaluations, and improve resource utilisation, P&R agencies should build on the official decisions and recommendations made for OMPs at a European level, tailoring and adapting these assessments to their local environment. Currently, the duplication of regulatory and HTA activities at a national level contributes to the lengthy and often variable access to OMPs across Member States [64].